![Shawn Titcomb](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Shawn Titcomb
Direttore/Membro del Consiglio presso Praesidia Biotherapeutics, Inc.
Patrimonio netto: 2 M $ in data 30/06/2024
Posizioni attive di Shawn Titcomb
Società | Posizione | Inizio | Fine |
---|---|---|---|
Praesidia Biotherapeutics, Inc.
![]() Praesidia Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Praesidia Biotherapeutics, Inc. is a company that specializes in developing drugs using their proprietary Tunable Linker Technology called LESS (Linker Enzyme Substrate System). The company is based in Arlington, MA. This technology helps to maximize the therapeutic potential of drugs. The company was founded by Sohang Chatterjee, Pradip K. Majumder, and Santosh Kesari, with Sohang Chatterjee serving as the CEO since incorporation. | Direttore/Membro del Consiglio | 01/07/2021 | - |
Independent Dir/Board Member | 01/07/2021 | - |
Storia della carriera di Shawn Titcomb
Precedenti posizioni note di Shawn Titcomb
Società | Posizione | Inizio | Fine |
---|---|---|---|
Noble Capital Markets, Inc.
![]() Noble Capital Markets, Inc. Investment Banks/BrokersFinance Founded in 1984, Noble Financial Capital Markets is a broker/dealer headquartered in Boca Raton, Florida. The firm is a subsidiary of Noble Financial Group, Inc. Noble Financial Capital Markets' sales & trading team provides strategic insight and reliable solutions to nearly 500 of the dominant small-cap money managers in North America. They are members FINRA, SIPC and MSRB. Noble Financial Capital Markets offers a full array of investment services with a particular focus on under-followed, undervalued, out-of-favor small-cap emerging growth companies. Their research coverage universe includes healthcare, business services & software, defense/defense technology, energy, enterprise hardware, and media & entertainment. | Corporate Officer/Principal | - | - |
COYA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | - | - |
ZyVersa Therapeutics Operating, Inc.
![]() ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL. | Presidente | 01/01/2014 | - |
Fondatore | 01/01/2014 | - | |
Avalon Research Group, Inc. | Vendite & Marketing | - | - |
Variant Trading Institutional Group, Inc.
![]() Variant Trading Institutional Group, Inc. Investment Banks/BrokersFinance Variant Trading Institutional Group, Inc. operates as a brokerage firm. It specializes in the business of buying and selling securities such as stocks, bonds, mutual funds and other investment products. The company was founded in 2003 and is headquartered in Boca Raton, FL. | Vendite & Marketing | - | - |
Formazione di Shawn Titcomb
University of Denver | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Posizioni
Sales & Marketing | 2 |
Director/Board Member | 2 |
Corporate Officer/Principal | 1 |
Settori
Finance | 4 |
Health Technology | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
COYA THERAPEUTICS, INC. | Health Technology |
Aziende private | 5 |
---|---|
Variant Trading Institutional Group, Inc.
![]() Variant Trading Institutional Group, Inc. Investment Banks/BrokersFinance Variant Trading Institutional Group, Inc. operates as a brokerage firm. It specializes in the business of buying and selling securities such as stocks, bonds, mutual funds and other investment products. The company was founded in 2003 and is headquartered in Boca Raton, FL. | Finance |
Avalon Research Group, Inc. | Finance |
Noble Capital Markets, Inc.
![]() Noble Capital Markets, Inc. Investment Banks/BrokersFinance Founded in 1984, Noble Financial Capital Markets is a broker/dealer headquartered in Boca Raton, Florida. The firm is a subsidiary of Noble Financial Group, Inc. Noble Financial Capital Markets' sales & trading team provides strategic insight and reliable solutions to nearly 500 of the dominant small-cap money managers in North America. They are members FINRA, SIPC and MSRB. Noble Financial Capital Markets offers a full array of investment services with a particular focus on under-followed, undervalued, out-of-favor small-cap emerging growth companies. Their research coverage universe includes healthcare, business services & software, defense/defense technology, energy, enterprise hardware, and media & entertainment. | Finance |
ZyVersa Therapeutics Operating, Inc.
![]() ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL. | Health Technology |
Praesidia Biotherapeutics, Inc.
![]() Praesidia Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Praesidia Biotherapeutics, Inc. is a company that specializes in developing drugs using their proprietary Tunable Linker Technology called LESS (Linker Enzyme Substrate System). The company is based in Arlington, MA. This technology helps to maximize the therapeutic potential of drugs. The company was founded by Sohang Chatterjee, Pradip K. Majumder, and Santosh Kesari, with Sohang Chatterjee serving as the CEO since incorporation. | Health Services |
- Borsa valori
- Insiders
- Shawn Titcomb
- Esperienza